Day: July 18, 2024

Howard Hughes Holdings Inc. Board of Directors Approves Separation of Seaport Entertainment Group Inc.

THE WOODLANDS, Texas, July 18, 2024 (GLOBE NEWSWIRE) — Howard Hughes Holdings Inc. (NYSE: HHH) (the “Company” or “HHH”) announced today that its Board of Directors has authorized and declared a pro rata distribution (the “Distribution”) of 100% of the outstanding shares of common stock of Seaport Entertainment Group Inc. (“Seaport Entertainment”) to holders of record of HHH common stock as of the close of business on July 29, 2024 (the “Record Date”). The Distribution is expected to be payable after market close on July 31, 2024 (the “Distribution Date”). As a result of the Distribution, holders of HHH common stock will receive one share of Seaport Entertainment common stock for every nine shares of HHH common stock held at the close of business on the Record Date. Fractional shares of Seaport Entertainment common stock will not...

Continue reading

Vision Sensing Acquisition Corp. Announces Successful Application to Nasdaq Stock Exchange for VSAC to Migrate to the Nasdaq Capital Market

New York, NY, July 18, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose acquisition company, announced today that it has successfully applied to Nasdaq Stock Exchange to migrate to the Capital Market. VSAC previously announced, on January 23, 2024, that VSAC had received a staff determination letter, on January 17, 2024, from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company of the determination from the Nasdaq Staff (the “Staff”) to delist the Company’s securities from The Nasdaq Stock Market and that VSAC had submitted a request to appeal Staff’s determination to a Hearings Panel. On January 26, 2024, VSAC issued a further press release announcing that, on January 24, 2024, VSAC was notified, by a Nasdaq Hearings Advisor,...

Continue reading

LiveOne (Nasdaq: LVO) Provides Updated Preliminary Record Breaking Revenue and EBITDA results for Q1 FY2025

Expected Record Revenue of $33.1M for Q1 FY2025, up 20% from Q1 FY2024 Expected Adjusted EBITDA* of $2.9M, up 31% over Q1 FY2024 Guides positive cash flow from core operating business of $17.5M for fiscal year ending March 31, 2025 (“FY2025”) Realized annualized cost savings of approximately $5M for Q1 FY2025 and ended Q1 FY2025 with over $10M cash position Company expands share repurchase program from $10M to $12M LOS ANGELES, July 18, 2024 (GLOBE NEWSWIRE) — LiveOne (Nasdaq: LVO), a creator-first music, entertainment, and technology platform, announced today certain of its preliminary and unaudited results for the first fiscal quarter ended June 30, 2024 (“Q1 FY2025”). “We’re thrilled to announce our anticipated record-breaking Q1 FY2025 results, driven by strong revenue growth and cost savings initiatives,” said...

Continue reading

ABM Among 60 Best Companies to Sell For

NEW YORK, July 18, 2024 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of integrated facility services, infrastructure solutions, and parking management, today announced it has been named one of Selling Power Magazine’s 60 Best Companies to Sell For in 2024. This is the third consecutive year ABM has been named to the list, recognizing the top companies leading in the alignment of people, processes, and technologies to create effective sales cultures. “We are honored to once again be recognized as one of the best companies to sell for, reflecting our industry-leading sales culture across ABM,” said Sean Mahoney, EVP, Sales and Marketing at ABM. “A key pillar of ABM’s ELEVATE strategy is our continuous commitment to improving both client and team member experiences, bolstering not only our offerings but also our means of...

Continue reading

Pactiv Evergreen Inc. Schedules Second Quarter 2024 Financial Results

LAKE FOREST, Ill., July 18, 2024 (GLOBE NEWSWIRE) — Pactiv Evergreen (NASDAQ: PTVE) today announced the following details for its second quarter 2024 earnings release and teleconference call. Earnings Release: Wednesday, July 31, 2024, after market close Webcast and Teleconference: Thursday, August 1, 2024, at 8:30 a.m. EDT Pactiv Evergreen Participants: Michael King, President and Chief Executive Officer   Jon Baksht, Chief Financial Officer   Curt Worthington, VP, Strategy & Investor Relations     Participants may access the live webcast on the Company’s Investor Relations website at https://investors.pactivevergreen.com/news-events/events-presentations. To join by phone, participants can register for the call here. It is recommended that participants register at least 15 minutes before the call. Once registered,...

Continue reading

MARKSMEN ANNOUNCES FURTHER EXTENSION OF PREVIOUSLY ANNOUNCED PRIVATE PLACEMENT

CALGARY, ALBERTA, July 18, 2024 (GLOBE NEWSWIRE) — Marksmen Energy Inc. (TSXV: MAH) (“Marksmen” or the “Company”) announces that, further to its news releases dated May 10 and June 19, 2024, the TSX Venture Exchange has granted an extension to the Company to August 23, 2024 to complete its previously announced non-brokered private placement of up to 30,000,000 units of Marksmen (“Units”) at a price of $0.01 per Unit for aggregate gross proceeds of up to a maximum of $300,000 (the “Offering”). Completion of the Offering is subject to regulatory approval including, but not limited to, the approval of the TSX Venture Exchange. For additional information regarding this news release please contact Archie Nesbitt, Director, and CEO of the Company at (403) 265-7270 or e-mail ajnesbitt@marksmenenergy.com. Neither the TSX Venture Exchange...

Continue reading

Abliva Announces Positive Interim Analysis of the FALCON Study for KL1333 in Primary Mitochondrial Disease

– Independent committee confirms FALCON study is powered for potential success with both alternative endpoints passing futility- -Committee confirms strong safety profile of KL1333- – Abliva to host conference call and webcast on Friday 19 July at 4:30 pm CET / 10:30 am ET – LUND, Sweden, July 18, 2024 (GLOBE NEWSWIRE) — Abliva AB (Nasdaq Stockholm: ABLI), a clinical-stage company developing drugs for the treatment of rare and severe primary mitochondrial disease, today announced a positive outcome of the interim analysis for FALCON, the potentially registrational study evaluating KL1333 in patients with primary mitochondrial disease. The study evaluates fatigue and myopathy as alternative independent primary endpoints, only one of which is required for a successful study readout. The independent Data Monitoring Committee...

Continue reading

Appili Therapeutics Announces Second Amendment to Arrangement Agreement

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, July 18, 2024 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, announces that it has entered into a second amending agreement (the “Amending Agreement”) among the Company, Aditxt, Inc. (“Aditxt”) and Adivir, Inc. (“Adivir” and together with the Company and Aditxt, the “Parties”) to amend the previously announced arrangement agreement dated April 1, 2024 among the Parties (as amended on July 1, 2024, the “Arrangement Agreement”), pursuant to which Aditxt, through its wholly-owned subsidiary, Adivir, will acquire all of the issued and outstanding Class A...

Continue reading

Middlefield Banc Corp. Reports 2024 Six-Month Financial Results

MIDDLEFIELD, OHIO, July 18, 2024 (GLOBE NEWSWIRE) — Middlefield Banc Corp. (NASDAQ: MBCN) today reported financial results for the six months ended June 30, 2024. 2024 Six-Month Financial Highlights (on a year-over-year basis): Net income was $8.3 million, compared to $10.0 million Pre-tax, pre-provision net income(1) was $9.7 million, compared to $13.3 million   Earnings were $1.03 per diluted share, compared to $1.23 per diluted share Net interest income after the provision for credit losses was $30.1 million, compared to $32.5 million Noninterest income increased 8.7% to $3.6 million, compared to $3.3 million Total loans increased 6.3% to a record  $1.50 billion, compared to $1.41 billion Total deposits increased 2.6% to a record $1.47 billion, compared to $1.43 billion Return on average assets annualized was 0.91%, compared...

Continue reading

Centerra Gold Publishes 2023 Environmental, Social and Governance Report

TORONTO, July 18, 2024 (GLOBE NEWSWIRE) — Centerra Gold Inc. (“Centerra” or the “Company”) (TSX: CG) (NYSE: CGAU) has published its 2023 Environmental, Social and Governance (“ESG”) Report, which outlines the Company’s performance on sustainability-related material topics. Key highlights and achievements from the report are included below. The full report can be accessed on Centerra’s website at www.centerragold.com/sustainability. Paul Tomory, President and Chief Executive Officer of Centerra, commented “2023 was a year of meaningful progress in our sustainability journey, marked by significant achievements across the organization. We recognize that ESG contributes to the long-term sustainability, profitability and growth of our Company. Centerra’s dedication to ESG is an important aspect of our corporate identity,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.